Abstract

BackgroundExtensive passage of adipose-derived stem cells (ASCs) in vitro leads to loss of function. Endothelial colony-forming cells (ECFCs) can be isolated from adult peripheral blood. A 3D co-culture system may rescue in vitro ASC senescence.MethodsA 3D co-culture model was successfully established using hyaluronic acid (HA) gel and a 10:1 ratio of late-passage ASCs and ECFCs. Cell density and culture conditions were optimized. Stem cell phenotype was characterized by flow cytometry. ELISA was used to measure the trophic effect of angiogenic growth factors and compare the effects of these factors between the 3-D co-culture and single-cell culture. Therapeutic potential of ASC/ECFC 3-D co-cultures was evaluated in a mouse chronic injury model.ResultsFollowing incubation in a HA substrate 3D co-culture system, ASC morphology, phenotype, secretory profile, and differentiation capacity were restored. The ASC/ECFC co-culture increased the secretion of cytokines, such as hepatocyte growth factor, compared with single-cell 3D culture or monolayer culture. Mice radiation-ulcer wounds treated with ASC/ECFC 3-D co-cultures (spheroids) showed epithelialization and improved healing compared with wounds treated with ASCs or ECFCs alone. Further, transplanted ASC/ECFC spheroids exhibited superior angiogenic potential due to the ability of the ASCs to transdifferentiate into pericytes.Conclusion3D co-culture of ECFCs and ASCs in vitro restored native ASC properties by reversing cellular senescence and loss of trophic function. Transplant of ASC/ECFC 3D spheroids in vivo demonstrated pro-angiogenic capacity with improved therapeutic potential.

Highlights

  • Extensive passage of adipose-derived stem cells (ASCs) in vitro leads to loss of function

  • Endothelial colony-forming cells (ECFCs) characterization ECFCs were identified by positive expression of characteristic markers including CD31, VEGFR2, eNOS, and CD105, and negative expression of CD133 and CD45

  • Flow cytometry analysis revealed that ECFCs and ASCs had similar size and granularity

Read more

Summary

Introduction

Extensive passage of adipose-derived stem cells (ASCs) in vitro leads to loss of function. Given the high rate of depression reported in patients with chronic wounds, new treatments need to be developed for improved therapeutic outcomes. Advances in regenerative medicine, including the development of stem cell therapy, have led to possible treatments for chronic wounds. Human adipose-derived stem cells (ASCs) are an abundant source of multipotent adult mesenchymal stem cells that are obtained from subcutaneous adipose tissue via liposuction. There has been a substantial increase in the number of clinical trials using human ASCs based on their established roles in immune modulation, trophic function, multipotency, and accessibility from patients [1]. It is essential to culture and expand ASCs in vitro before they can be used therapeutically

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call